08/07/2018

Newsletters of Interest

A Few Articles You Won’t Want to Miss:

• Our office manual keeps you informed
• The appeals address for commercial Coventry plans has changed
• Don’t let your network status change — complete your FDR attestation today
• Help is available if you’re having issues with the new Medicare cards
• Important pharmacy updates

And Much More….JUNE Mid-America Region Qtly Issue Available HERE

A Few Articles You Won’t Want to Miss:

• BCN is updating its clinical editing system
• Blue Care Network updates professional fees July 1
• Helpful hints to expedite your Provider Secured Services application
• Starting Oct. 1, additional specialty medications require authorization for BCN Advantage members
• BCBSM and BCN drug lists updated, available online
• How to accurately code for immunosuppression and immunodeficiency

And Much More…JULY/AUGUST Bi-Monthly Issue Available HERE

Current Issue Available HERE

Current Issue Available HERE   (once on the site, choose NEWS on the left side)

A Few Articles You Won’t Want to Miss:

• Prepare Now for Portal Closure (Oct. 3, 2018)
• Access FAQs for Information about Required Compliance Training
• Online Tool Provides Faster Preauthorization Determinations
• Manage Medical Record Requests with Ease
• Peer-to-peer Review Process Changing for Humana Medicare Advantage (MA) Products

And Much More…Latest Issue Available HERE

 A Few Articles You Won’t Want to Miss:

• Front & Center
  • New Smart Edits Deploying on Aug. 16 and Sept. 10
  • Free CEU/CME Educational Credits Now Available on UHC On Air
  • Pharmacy Update: Notice of Changes to Prior Authorization Requirements and
    Coverage Criteria for UnitedHealthcare Commercial and Oxford

• UnitedHealthcare Reimbursement Policies
  • Pharmacy Update: Notice of Changes to Prior Authorization Requirements and
    Coverage Criteria for UnitedHealthcare Commercial and Oxford

• UnitedHealthcare Medicare Advantage
  • UnitedHealthcare Medicare Advantage Plan Reimbursement — New Policies
  • Reminder: National Drug Code (NDC) Requirement Policy

And Much More…AUGUST Monthly Issue Available HERE

Oncology Related Articles You Won’t Want to Miss:

Medical Policy Updates

Updated:

• Chemosensitivity and Chemoresistance Assays in Cancer – Effective Aug. 1, 2018

Revised:

• Genetic Testing for Hereditary Cancer – Effective Oct. 1, 2018
• Molecular Oncology Testing for Cancer Diagnosis, Prognosis, and Treatment Decisions – Effective Oct. 1, 2018

Medical Benefit Drug Policy Updates

Updated:

• Entyvio^® (Vedolizumab) – Effective Aug. 1, 2018

Revised:

• Erythropoiesis-Stimulating Agents – Effective Aug. 1, 2018
• Soliris® (Eculizumab) – Effective Aug. 1, 2018

Coverage Determination Guideline Updates

Updated:

• Home Health Care – Effective Aug. 1, 2018
• Skilled Care and Custodial Care Services – Effective Aug. 1, 2018

AUGUST Monthly Issue Available HERE